Johnson & Johnson (JNJ)
Largest Insider Buys in Sector
JNJ Stock Price History Chart
JNJ Stock Performance
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Activity of Johnson & Johnson
Over the last 12 months, insiders at Johnson & Johnson have bought $0 and sold $16.66M worth of Johnson & Johnson stock.
On average, over the past 5 years, insiders at Johnson & Johnson have bought $1.54M and sold $36.7M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $127,686 was made by PEREZ WILLIAM D (director) on 2020‑03‑13.
List of Insider Buy and Sell Transactions, Johnson & Johnson
| 2024-03-13 | Sale | Broadhurst Vanessa | EVP, Global Corp Affairs | 8,891 0.0004% | $162.16 | $1.44M | -7.44% | |
| 2024-02-09 | Sale | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 59,397 0.0024% | $156.27 | $9.28M | -3.52% | |
| 2023-07-26 | Sale | Hait William | See Remarks | 14,698 0.0006% | $172.00 | $2.53M | -9.63% | |
| 2023-07-25 | Sale | Fasolo Peter | Exec VP, Chief HR Officer | 20,000 0.0008% | $170.32 | $3.41M | -9.39% | |
| 2023-06-12 | Sale | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 12,465 0.0005% | $160.00 | $1.99M | -1.34% | |
| 2023-03-06 | Sale | Swanson James D. | See Remarks | 1,061.68 <0.0001% | $154.66 | $164,199 | +3.00% | |
| 2022-12-13 | Sale | Wolk Joseph J | Exec VP, CFO | 14,781 0.0006% | $179.60 | $2.65M | -9.46% | |
| 2022-11-30 | Sale | McEvoy Ashley | EVP, WW Chair, MedTech | 73,323 0.0027% | $175.47 | $12.87M | -8.48% | |
| 2022-11-22 | Sale | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 76,923 0.0029% | $176.78 | $13.6M | -7.60% | |
| 2022-11-18 | Sale | Decker Robert J | Controller, CAO | 16,928 0.0006% | $175.00 | $2.96M | -6.62% | |
| 2022-11-09 | Sale | Wengel Kathryn E | EVP, Chief GSC Officer | 16,410 0.0006% | $173.42 | $2.85M | -4.34% | |
| 2022-11-04 | Sale | Mongon Thibaut | Exec VP, WW Chair, Consumer | 35,246 0.0013% | $171.18 | $6.03M | -3.71% | |
| 2022-10-24 | Sale | Fasolo Peter | Exec VP, Chief HR Officer | 9,064 0.0003% | $171.36 | $1.55M | -2.95% | |
| 2022-10-24 | Sale | Fasolo Peter | Exec VP, Chief HR Officer | 78,458 0.003% | $171.25 | $13.44M | -2.95% | |
| 2022-10-24 | Sale | Hait William | See Remarks | 15,000 0.0006% | $171.55 | $2.57M | -2.95% | |
| 2022-10-19 | Sale | Fasolo Peter | Exec VP, Chief HR Officer | 92,990 0.0035% | $164.50 | $15.3M | +0.97% | |
| 2022-10-19 | Sale | Fasolo Peter | Exec VP, Chief HR Officer | 67,591 0.0026% | $164.50 | $11.12M | +0.97% | |
| 2022-06-10 | Sale | Wengel Kathryn E | EVP, Chief GSC Officer | 73,126 0.0028% | $173.00 | $12.65M | -2.88% | |
| 2022-05-26 | Sale | Decker Robert J | Controller, CAO | 16,924 0.0006% | $180.00 | $3.05M | -6.09% | |
| 2022-04-21 | Sale | Hait William | See Remarks | 31,102 0.0012% | $183.58 | $5.71M | -5.97% |
Insider Historical Profitability
| Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 141416 0.0059% | $146.82 | 0 | 2 | |
| Fasolo Peter | Exec VP, Chief HR Officer | 102696 0.0043% | $146.82 | 0 | 11 | |
| Hait William | See Remarks | 87747 0.0036% | $146.82 | 0 | 3 | |
| Broadhurst Vanessa | EVP, Global Corp Affairs | 15043 0.0006% | $146.82 | 0 | 1 | |
| WILSON ROBERT N | Retired Director/Vice Chairman | 889154 0.0369% | $146.82 | 0 | 1 | |
| WELDON WILLIAM C | Former Chairman of the Board | 407364 0.0169% | $146.82 | 0 | 9 | |
| Gorsky Alex | Chairman, CEO | 336559 0.014% | $146.82 | 0 | 1 | |
| DARRETTA ROBERT J | Vice Chairman | 209118 0.0087% | $146.82 | 0 | 3 | |
| Stoffels Paulus | Exec VP, Chief Scientific Off | 202564 0.0084% | $146.82 | 0 | 6 | |
| LENEHAN JAMES T | Former Vice Chairman/Director | 199372 0.0083% | $146.82 | 0 | 1 | |
| FINE ROGER S | Retired Exec Committee Member | 191226 0.0079% | $146.82 | 0 | 1 | |
| HEISEN JOANN HEFFERNAN | VP, Chief Information Officer | 161864 0.0067% | $146.82 | 0 | 4 | |
| Caruso Dominic J | Exec VP, Finance; CFO | 144102 0.006% | $146.82 | 0 | 9 | |
| GOGGINS COLLEEN A | Member, Executive Committee | 105922 0.0044% | $146.82 | 0 | 9 | |
| Ullmann Michael H | Exec VP, General Counsel | 97455 0.004% | $146.82 | 0 | 4 | |
| Duato Joaquin | Vice Chair, Exec Committee | 93555 0.0039% | $146.82 | 0 | 2 | |
| COSGROVE STEPHEN J | Corporate Controller | 90294 0.0038% | $146.82 | 0 | 13 | |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | 65934 0.0027% | $146.82 | 0 | 5 | |
| PERKINS BRIAN D | Former Member Exec Committee | 61899 0.0026% | $146.82 | 0 | 3 | |
| Sneed Michael E | EVP, Global Corp Aff & COO | 56079 0.0023% | $146.82 | 0 | 4 | |
| VALERIANI NICHOLAS J | VP, Strategy & Growth, other: Member, Executive Committee | 53318 0.0022% | $146.82 | 0 | 6 | |
| McCoy Sherilyn S | Member, Executive Committee | 49243 0.002% | $146.82 | 0 | 3 | |
| Pruden Gary J | Exec VP, WW Chair, Med Devices | 43630 0.0018% | $146.82 | 0 | 2 | |
| McEvoy Ashley | EVP, WW Chair, MedTech | 41813 0.0017% | $146.82 | 0 | 2 | |
| Mongon Thibaut | Exec VP, WW Chair, Consumer | 40133 0.0017% | $146.82 | 0 | 3 | |
| Wolk Joseph J | Exec VP, CFO | 35812 0.0015% | $146.82 | 0 | 1 | |
| PRINCE CHARLES | director | 28520 0.0012% | $146.82 | 6 | 0 | +5.17% |
| Casey Donald M Jr. | Member, Executive Committee | 22536 0.0009% | $146.82 | 0 | 1 | |
| DORMER MICHAEL J | Member, Executive Committee | 18499 0.0008% | $146.82 | 0 | 1 | |
| Scodari Joseph C | Retired Exec Committee Member | 18646 0.0008% | $146.82 | 0 | 2 | |
| PEREZ WILLIAM D | director | 16030 0.0007% | $146.82 | 14 | 0 | +2.64% |
| PETERSON PER A | Executive Committee Member | 14195 0.0006% | $146.82 | 0 | 6 | |
| Decker Robert J | Controller, CAO | 15473 0.0006% | $146.82 | 0 | 4 | |
| COLEMAN MARY SUE | director | 14352 0.0006% | $146.82 | 0 | 1 | |
| Kapusta Ronald A | Controller, CAO | 13641 0.0006% | $146.82 | 0 | 8 | |
| LINDQUIST SUSAN L | director | 14605 0.0006% | $146.82 | 0 | 1 | |
| Swanson James D. | See Remarks | 9215 0.0004% | $146.82 | 0 | 1 | |
| MULCAHY ANNE M | director | 6537 0.0003% | $146.82 | 1 | 0 | +1.82% |
| LANGBO ARNOLD G | director | 6367 0.0003% | $146.82 | 0 | 5 | |
| Joly Hubert | director | 5000 0.0002% | $146.82 | 1 | 0 | +5.24% |
| JORDAN ANN DIBBLE | director | 5933 0.0002% | $146.82 | 0 | 1 | |
| Foster-Cheek Kaye I | VP, Human Resources | 4583 0.0002% | $146.82 | 0 | 1 | |
| CULLEN JAMES | director | 1489 0.0001% | $146.82 | 0 | 12 | |
| SATCHER DAVID | director | 2491 0.0001% | $146.82 | 1 | 0 | +1.72% |
| DEYO RUSSELL C | VP, General Counsel | 2478 0.0001% | $146.82 | 0 | 21 | |
| HEWSON MARILLYN A | director | 3000 0.0001% | $146.82 | 1 | 0 | +0.22% |
Institutional Investor Ownership
| The Vanguard Group | $36.22B | 9.51 | 228.94M | -0.2% | -$71.05M | 0.69 | |
| BlackRock | $30.01B | 7.88 | 189.73M | +1.83% | +$540.76M | 0.68 | |
| State Street | $21.12B | 5.55 | 133.52M | +0.46% | +$97.36M | 0.91 | |
| Geode Capital Management | $8.42B | 2.22 | 53.32M | +4.03% | +$326.07M | 0.75 | |
| Morgan Stanley | $6.73B | 1.77 | 42.55M | +2.14% | +$140.86M | 0.52 | |
| State Farm | $5.01B | 1.32 | 31.68M | 0% | +$0 | 4.51 | |
| JPMorgan Chase | $4.72B | 1.24 | 29.85M | +0.34% | +$16.23M | 0.42 | |
| Northern Trust | $4.53B | 1.19 | 28.63M | -3.69% | -$173.73M | 0.77 | |
| Wellington Management Company | $3.76B | 0.99 | 23.75M | -1.14% | -$43.15M | 0.64 | |
| Bank of America | $3.75B | 0.99 | 23.72M | +7.33% | +$256.24M | 0.36 | |
| Legal & General | $3.68B | 0.97 | 23.26M | +5.23% | +$183.02M | 0.86 | |
| BNY Mellon | $3.5B | 0.92 | 22.14M | -0.37% | -$12.97M | 0.66 | |
| T. Rowe Price | $3.45B | 0.91 | 21.83M | +16.79% | +$496.64M | 0.42 | |
| Wells Fargo | $2.95B | 0.77 | 18.63M | -0.17% | -$5.15M | 0.79 | |
| Capital International Investors | $2.71B | 0.71 | 17.16M | -40.81% | -$1.87B | 0.55 | |
| Massachusetts Financial Services Co Ma | $2.68B | 0.7 | 16.95M | +0.27% | +$7.21M | 0.8 | |
| Fidelity Investments | $2.67B | 0.7 | 16.88M | +1.34% | +$35.26M | 0.18 | |
| Charles Schwab | $2.54B | 0.67 | 16.18M | +1.46% | +$36.53M | 0.58 | |
| Invesco | $2.26B | 0.59 | 14.27M | +7.42% | +$155.87M | 0.48 | |
| Deutsche Bank | $2.23B | 0.59 | 14.1M | +9% | +$184.13M | 1.02 | |
| Ameriprise Financial | $2.15B | 0.57 | 13.62M | +8.74% | +$173.22M | 0.6 | |
| Royal Bank of Canada | $2.11B | 0.55 | 13.31M | -0.91% | -$19.38M | 0.5 | |
| Ubs Asset Management Americas Inc | $2.09B | 0.55 | 13.23M | -6.45% | -$144.29M | 0.75 | |
| Franklin Templeton Investments | $1.97B | 0.52 | 12.46M | +13.62% | +$236.32M | 0.59 | |
| Dimensional Fund Advisors | $1.79B | 0.47 | 11.32M | +11.3% | +$181.75M | 0.48 | |
| CalPERS | $1.68B | 0.44 | 10.64M | +0.2% | +$3.4M | 1.18 | |
| Robert Wood Johnson Foundation | $1.64B | 0.43 | 10.37M | -4.33% | -$74.3M | 96.2 | |
| Goldman Sachs | $1.64B | 0.43 | 10.36M | -21.34% | -$444.51M | 0.31 | |
| UBS | $1.59B | 0.42 | 10.03M | +14.88% | +$205.51M | 0.48 | |
| Amundi | $1.46B | 0.42 | 9.99M | +16.48% | +$206.17M | 0.61 | |
| HSBC | $1.58B | 0.42 | 9.99M | +21.17% | +$275.97M | 1.13 | |
| Nuveen | $1.47B | 0.39 | 9.28M | -1.52% | -$22.62M | 0.43 | |
| Barclays | $1.31B | 0.35 | 8.31M | -7.13% | -$100.96M | 0.6 | |
| Nordea Investment Management Ab | $1.21B | 0.32 | 7.65M | -3.95% | -$49.9M | 1.43 | |
| American Century Investments | $1.2B | 0.32 | 7.58M | +5.82% | +$65.93M | 0.73 | |
| Swiss National Bank | $1.14B | 0.3 | 7.21M | -4.26% | -$50.7M | 0.78 | |
| Journey Strategic Wealth Llc | $1.09B | 0.29 | 6.88M | +0.01% | +$151,546.02 | 48.64 | |
| Fisher Asset Management Llc | $1.05B | 0.28 | 6.62M | +4.29% | +$43.13M | 0.49 | |
| PNC Financial Services | $1.02B | 0.27 | 6.47M | -3.35% | -$35.48M | 0.72 | |
| Sumitomo Mitsui Trust Holdings | $1.01B | 0.27 | 6.4M | -0.62% | -$6.29M | 0.69 | |
| Raymond James Associates | $1.01B | 0.27 | 6.38M | +5.32% | +$51.04M | 0.68 | |
| Flossbach von Storch | $955.57M | 0.25 | 6.04M | -1.18% | -$11.41M | 4.17 | |
| Neuberger Berman | $949.64M | 0.25 | 6M | -9.38% | -$98.25M | 0.79 | |
| LAZARD ASSET MANAGEMENT LLC | $930.1M | 0.24 | 5.88M | -0.93% | -$8.77M | 1.23 | |
| ClearBridge Investments | $920.85M | 0.24 | 5.82M | -7.38% | -$73.4M | 0.74 | |
| Credit Suisse | $915.09M | 0.24 | 5.79M | -6.34% | -$61.91M | 0.84 | |
| Bank of Montreal | $865.73M | 0.23 | 5.44M | -16.54% | -$171.59M | 0.27 | |
| AllianceBernstein | $822.36M | 0.22 | 5.2M | -6.16% | -$54.01M | 0.29 | |
| Grantham Mayo Van Otterloo & Co LLC | $763.67M | 0.2 | 4.83M | +21.1% | +$133.06M | 2.79 | |
| DekaBank | $709.44M | 0.19 | 4.48M | +1.97% | +$13.71M | 1.32 |